Laurie Feldman

1.4k total citations
34 papers, 717 citations indexed

About

Laurie Feldman is a scholar working on Molecular Biology, Physiology and Hematology. According to data from OpenAlex, Laurie Feldman has authored 34 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Physiology and 15 papers in Hematology. Recurrent topics in Laurie Feldman's work include Erythrocyte Function and Pathophysiology (15 papers), Erythropoietin and Anemia Treatment (10 papers) and Blood properties and coagulation (7 papers). Laurie Feldman is often cited by papers focused on Erythrocyte Function and Pathophysiology (15 papers), Erythropoietin and Anemia Treatment (10 papers) and Blood properties and coagulation (7 papers). Laurie Feldman collaborates with scholars based in United States, Pakistan and Poland. Laurie Feldman's co-authors include Arthur J. Sytkowski, Jee‐Yeong Jeong, Cécile Rouleau, Peter Solár, Gabriel Wcisło, Cezary Szczylik, Nicholas Dainiak, Eliezer Rapaport, Massimo Loda and Nandita Bhattacharya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Laurie Feldman

34 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurie Feldman United States 16 320 303 155 149 99 34 717
LJ Fairbairn United Kingdom 17 207 0.6× 566 1.9× 114 0.7× 295 2.0× 172 1.7× 32 1.0k
Beatriz Albella Spain 14 256 0.8× 318 1.0× 37 0.2× 168 1.1× 76 0.8× 31 803
John W. Madsen United States 10 79 0.2× 469 1.5× 261 1.7× 89 0.6× 48 0.5× 11 791
Pacifico Meo Italy 7 190 0.6× 339 1.1× 111 0.7× 62 0.4× 46 0.5× 13 573
Deborah Chirnomas United States 10 237 0.7× 580 1.9× 91 0.6× 294 2.0× 62 0.6× 18 898
Yuh‐Ching Twu Taiwan 18 269 0.8× 263 0.9× 248 1.6× 56 0.4× 90 0.9× 36 737
Rama Kannan France 15 143 0.4× 446 1.5× 264 1.7× 330 2.2× 56 0.6× 22 1.0k
O Babuŝíková Slovakia 11 184 0.6× 339 1.1× 24 0.2× 132 0.9× 25 0.3× 83 677
S P Treon United States 13 457 1.4× 540 1.8× 42 0.3× 447 3.0× 30 0.3× 20 958
Esther Rabizadeh Israel 14 94 0.3× 372 1.2× 80 0.5× 104 0.7× 24 0.2× 41 649

Countries citing papers authored by Laurie Feldman

Since Specialization
Citations

This map shows the geographic impact of Laurie Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Feldman more than expected).

Fields of papers citing papers by Laurie Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Feldman. The network helps show where Laurie Feldman may publish in the future.

Co-authorship network of co-authors of Laurie Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Feldman. A scholar is included among the top collaborators of Laurie Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Feldman. Laurie Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeong, Jee‐Yeong, Jin‐Rong Zhou, Chong Gao, Laurie Feldman, & Arthur J. Sytkowski. (2014). Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells. BMB Reports. 47(7). 411–416. 24 indexed citations
2.
Jeong, Jee‐Yeong, Gerta Hoxhaj, Amanda Socha, Arthur J. Sytkowski, & Laurie Feldman. (2009). An Erythropoietin Autocrine/Paracrine Axis Modulates the Growth and Survival of Human Prostate Cancer Cells. Molecular Cancer Research. 7(7). 1150–1157. 35 indexed citations
3.
Solár, Peter, et al.. (2007). Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel‐resistant phenotype. International Journal of Cancer. 122(2). 281–288. 29 indexed citations
4.
Jeong, Jee‐Yeong, et al.. (2007). Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells. International Journal of Cancer. 122(2). 274–280. 58 indexed citations
5.
Debeljak, Nataša, et al.. (2006). Variability in the immunodetection of His-tagged recombinant proteins. Analytical Biochemistry. 359(2). 216–223. 36 indexed citations
6.
Xu, Kun, et al.. (2005). Erythropoietin and IL-3 receptor cell surface expression is decreased under conditions that model some aspects of microgravity.. PubMed. 18(2). 111–2. 2 indexed citations
7.
Sytkowski, Arthur J., et al.. (2005). Human selenium binding protein-1 (hSP56) inhibits anchorage-independent growth of PC-3 human prostate cancer cells and is down-regulated in primary human prostate tumor cells. Journal of Clinical Oncology. 23(16_suppl). 9564–9564. 1 indexed citations
8.
Feldman, Laurie, Yuxun Wang, Johng S. Rhim, et al.. (2005). Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. The Prostate. 66(2). 135–145. 79 indexed citations
9.
Rouleau, Cécile, et al.. (2004). A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl. Experimental Hematology. 32(2). 140–148. 8 indexed citations
10.
Feldman, Laurie & Arthur J. Sytkowski. (2003). Pleiotrophic actions of erythropoietin. Environmental Health and Preventive Medicine. 7(6). 239–245. 5 indexed citations
11.
Feldman, Laurie & Cécile Rouleau. (2002). Troponin I Inhibits Capillary Endothelial Cell Proliferation by Interaction with the Cell's bFGF Receptor. Microvascular Research. 63(1). 41–49. 29 indexed citations
12.
Feldman, Laurie, et al.. (1999). Isolation of Differentially Expressed Genes by Cloning Transcriptionally Active DNA Fragments. Methods. 17(3). 265–271. 5 indexed citations
13.
Duguid, William P., et al.. (1997). Apoptosis occurs in freshly isolated human islets under standard culture conditions. Transplantation Proceedings. 29(1-2). 750–752. 44 indexed citations
14.
Feldman, Laurie, et al.. (1992). B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.. PubMed. 20(10). 1223–8. 8 indexed citations
15.
Sytkowski, Arthur J., et al.. (1991). Biological activity and structural stability of N-deglycosylated recombinant human erythropoietin. Biochemical and Biophysical Research Communications. 176(2). 698–704. 20 indexed citations
16.
Feldman, Laurie & Nicholas Dainiak. (1989). B-lymphocyte-derived erythroid burst-promoting activity is distinct from other known lymphokines. Blood. 73(7). 1814–1820. 2 indexed citations
17.
Dainiak, Nicholas, Henry B. Warren, S Kreczko, et al.. (1988). Acetylated lipoproteins impair erythroid growth factor release from endothelial cells.. Journal of Clinical Investigation. 81(3). 834–843. 11 indexed citations
18.
Feldman, Laurie, et al.. (1985). Neutralization of erythroid burst-promoting activity in vitro with antimembrane antibodies. Blood. 65(4). 877–885. 11 indexed citations
19.
Feldman, Laurie, et al.. (1980). Conformational changes in the H3. H4 histone complex. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations
20.
Feldman, Laurie, et al.. (1980). Conformational changes in the H3 . H4 histone complex. Serological and circular dichroism studies.. Journal of Biological Chemistry. 255(15). 7059–7062. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LJ Fairbairn Breakdown of academic impact, for papers by Beatriz Albella Breakdown of academic impact, for papers by John W. Madsen Breakdown of academic impact, for papers by Pacifico Meo Breakdown of academic impact, for papers by Deborah Chirnomas Breakdown of academic impact, for papers by Yuh‐Ching Twu Breakdown of academic impact, for papers by Rama Kannan Breakdown of academic impact, for papers by O Babuŝíková Breakdown of academic impact, for papers by S P Treon Breakdown of academic impact, for papers by Esther Rabizadeh
Rankless by CCL
2026